by Stacey Johnson | Nov 6, 2020
We heard it first. If you attended the virtual Vancouver version of the 2020 Till & McCulloch Meetings, you had the opportunity to hear from Dr. Janet Rossant, Chair of the Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada, giving us a...
by Stacey Johnson | Oct 16, 2020
The news that Health Canada has approved gene therapy Luxturna to treat blindness couldn’t come at a better time, as October is Blindness Awareness Month. You don’t have to look far to find other high impact research on blindness happening right here in Toronto,...
by Jovana Drinjakovic | Sep 9, 2020
In 2015, Jason Moffat walked into Sheila Singh’s office at McMaster University and gave her a small vial of clear liquid. The vial contained ten milliliters, or two teaspoons, of an injectable antibody, created in Moffat’s lab in Toronto, with a street value of around...
by Stacey Johnson | Sep 4, 2020
In 2016, I stumbled upon the concept of a “blog carnival” and I was excited to give it a whirl. It was so much fun and such a success that, five years later, it is now a regular summer feature on Signals. You can look forward to it in the same way that...
by Michael May | Aug 26, 2020
It is difficult to imagine how many times the opening lines to Charles Dickens’ classic A Tale of Two Cities, written over 160 years ago, has been used to describe the world’s current state of affairs. Yet, I am challenged to identify any other time during my...
Comments